130 related articles for article (PubMed ID: 15504980)
1. Association of glomerulopathy with the 5'-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients.
Zhao HL; Tong PC; Lai FM; Tomlinson B; Chan JC
Diabetes; 2004 Nov; 53(11):2984-91. PubMed ID: 15504980
[TBL] [Abstract][Full Text] [Related]
2. Diabetic nephropathy is associated with the 5'-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes.
Liu YF; Wat NM; Chung SS; Ko BC; Lam KS
Diabet Med; 2002 Feb; 19(2):113-8. PubMed ID: 11874426
[TBL] [Abstract][Full Text] [Related]
3. Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis.
Xu M; Chen X; Yan L; Cheng H; Chen W
J Mol Endocrinol; 2008 May; 40(5):243-51. PubMed ID: 18434430
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.
Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY
Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443
[TBL] [Abstract][Full Text] [Related]
5. (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus.
Park HK; Ahn CW; Lee GT; Kim SJ; Song YD; Lim SK; Kim KR; Huh KB; Lee HC
Diabetes Res Clin Pract; 2002 Feb; 55(2):151-7. PubMed ID: 11796181
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.
Wang Y; Ng MC; Lee SC; So WY; Tong PC; Cockram CS; Critchley JA; Chan JC
Diabetes Care; 2003 Aug; 26(8):2410-5. PubMed ID: 12882871
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus.
Yamamoto T; Sato T; Hosoi M; Yoshioka K; Tanaka S; Tahara H; Nishizawa Y; Fujii S
Diabetes Obes Metab; 2003 Jan; 5(1):51-7. PubMed ID: 12542725
[TBL] [Abstract][Full Text] [Related]
8. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5'-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus.
Ichikawa F; Yamada K; Ishiyama-Shigemoto S; Yuan X; Nonaka K
Diabet Med; 1999 Sep; 16(9):744-8. PubMed ID: 10510950
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes.
Heesom AE; Hibberd ML; Millward A; Demaine AG
Diabetes; 1997 Feb; 46(2):287-91. PubMed ID: 9000706
[TBL] [Abstract][Full Text] [Related]
10. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
Lajer M; Tarnow L; Fleckner J; Hansen BV; Edwards DG; Parving HH; Boel E
Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790
[TBL] [Abstract][Full Text] [Related]
11. The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus.
Moczulski DK; Burak W; Doria A; Zychma M; Zukowska-Szczechowska E; Warram JH; Grzeszczak W
Diabetologia; 1999 Jan; 42(1):94-7. PubMed ID: 10027585
[TBL] [Abstract][Full Text] [Related]
12. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
[TBL] [Abstract][Full Text] [Related]
13. Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy.
Shah VO; Scavini M; Nikolic J; Sun Y; Vai S; Griffith JK; Dorin RI; Stidley C; Yacoub M; Vander Jagt DL; Eaton RP; Zager PG
J Clin Endocrinol Metab; 1998 Aug; 83(8):2886-91. PubMed ID: 9709964
[TBL] [Abstract][Full Text] [Related]
14. Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat.
Donnelly SM; Zhou XP; Huang JT; Whiteside CI
Biochem Cell Biol; 1996; 74(3):355-62. PubMed ID: 8883841
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus.
Neamat-Allah M; Feeney SA; Savage DA; Maxwell AP; Hanson RL; Knowler WC; El Nahas AM; Plater ME; Shaw J; Boulton AJ; Duff GW; Cox A
Diabet Med; 2001 Nov; 18(11):906-14. PubMed ID: 11703436
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics of nodular glomerulosclerosis in Chinese patients with type 2 diabetes.
Zhao HL; Lai FM; Tong PC; Tomlinson B; Chan JC
Am J Kidney Dis; 2004 Dec; 44(6):1039-49. PubMed ID: 15558525
[TBL] [Abstract][Full Text] [Related]
17. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.
Pugliese G; Pricci F; Pesce C; Romeo G; Lenti E; Caltabiano V; Vetri M; Purrello F; Di Mario U
Diabetes; 1997 Jul; 46(7):1198-206. PubMed ID: 9200656
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase genotypes and cardiorenal complications: an 8-year prospective analysis of 1,074 type 2 diabetic patients.
So WY; Wang Y; Ng MC; Yang X; Ma RC; Lam V; Kong AP; Tong PC; Chan JC
Diabetes Care; 2008 Nov; 31(11):2148-53. PubMed ID: 18716049
[TBL] [Abstract][Full Text] [Related]
19. Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease.
Adler SG; Feld S; Striker L; Striker G; LaPage J; Esposito C; Aboulhosn J; Barba L; Cha DR; Nast CC
Kidney Int; 2000 May; 57(5):2084-92. PubMed ID: 10792628
[TBL] [Abstract][Full Text] [Related]
20. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
Dalla Vestra M; Saller A; Mauer M; Fioretto P
J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
